Concepedia

Jingwei Li

JL

Statistics

Publications

30

Citations

1.4K

H-Index

19

Active since

2012

Affiliations

The George Institute for Global Health(Current)

UNSW Sydney

Xinqiao Hospital

The University of Sydney

University Medical Center Groningen

Jingwei Li is an author at The George Institute for Global Health specializing in medicine, pharmacology, and diabetes mellitus.

ORCID

Publications per year

2012–2024

30

Publications

30

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

Megumi Oshima, Brendon L. Neuen, Jingwei Li et al. · Journal of the American Society of Nephrology · 2020 · 172 citations · Full text

, , +17

Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes

Jingwei Li, Mark Woodward, Vlado Perkovic et al. · JACC Heart Failure · 2019 · 142 citations · Full text

, , +12

Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

Jingwei Li, Bruce Neal, Vlado Perkovic et al. · Kidney International · 2020 · 131 citations · Full text

, , +17

Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage

Biying Ji, Fei Zhou, Lijuan Han et al. · Translational Stroke Research · 2017 · 93 citations · Full text

, , +17

Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial

Taha Sen, Jingwei Li, Brendon L. Neuen et al. · Diabetologia · 2021 · 83 citations · Full text

, , +17

1–5 of 30